Lisanti Capital Growth, LLC Haemonetics Corp Transaction History

Lisanti Capital Growth, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$82.56 - $93.49 $6.47 Million - $7.33 Million	78,425 New	78,425 $7.03 Million
Q1 2023 May 05, 2023	SELL	$72.75 - $90.6 $2.93 Million - $3.65 Million	-40,245 Reduced 41.27%	57,275 $4.74 Million
Q4 2022 Feb 03, 2023	BUY	$73.85 - $86.14 $7.2 Million - $8.4 Million	97,520 New	97,520 $7.67 Million
Q4 2019 Feb 13, 2020	SELL	$114.37 - $129.46 $6.11 Million - $6.91 Million	-53,385 Closed	0 $0
Q3 2019 Nov 06, 2019	BUY	$117.16 - $138.52 $6.25 Million - $7.39 Million	53,385 New	53,385 $6.73 Million
Q1 2019 May 13, 2019	SELL	$83.25 - $102.12 $3.89 Million - $4.78 Million	-46,765 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$90.66 - $116.63 $2.05 Million - $2.64 Million	22,645 Added 93.88%	46,765 $4.68 Million
Q3 2018 Nov 05, 2018	BUY	$89.96 - $114.58 $2.17 Million - $2.76 Million	24,120 New	24,120 $2.76 Million

333

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.36B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.